Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-04-08 2020-04-08
Drug Identification Number 02362635 02362635
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name STERIMAX INC STERIMAX INC
Ingredients PIPERACILLIN TAZOBACTAM PIPERACILLIN TAZOBACTAM
Strength(s) 4.0G 0.5G 4.0G 0.5G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS 10 VIALS
ATC code J01CR J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-03-17 2020-03-17
Estimated end date Unknown Unknown
Actual end date 2020-04-07 2020-04-07
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments